Suboptimal Health Status
Conditions
Brief summary
The purpose of this study is to determine whether omega-3 fatty acids supplementation are effective in the improvement of suboptimal health status and cardiovascular risk.
Detailed description
The Suboptimal health status questionnaire (SHSQ-25) is used to evaluate the suboptimal health status. The SHSQ-25 includes 25 questions. The score of the SHSQ-25 is from 0 to 100. Suboptimal health status is defined as the SHSQ-25 score above than 35. The higher scores of the SHSQ-25 one gets, the more severity of suboptimal health status he/she has. All participants are asked to fill in the SHSQ-25 before and after the intervention. If the score decreases after the intervention, it means that the suboptimal health status has been improved.
Interventions
DIETARY_SUPPLEMENTOmega -3 fatty acids
Each subject assigned to active treatment group will receive 4 g/day capsule of omega-3 fatty acids.
DIETARY_SUPPLEMENTPlacebo: Corn oil
Each subject assigned to the control group will receive 4 g/day capsule of corn oil.
Sponsors
Chinese PLA General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
1. suboptimal health status, defined as the score of suboptimal health questionnaire ≥35. 2. at least one of cardiovascular risk factors: * overweight or obesity, defined as body mass index (BMI) ≥25 kg/m2. * systolic blood pressure ≥130 and \<140 mmHg and diastolic blood pressure \<90 mmHg, or diastolic blood pressure ≥85 and \<90 mmHg and systolic blood pressure \<140 mmHg * fasting plasma glucose ≥100 and \<126 mg/dL * total cholesterol ≥200 and \<240 mg/dL, triglyceride ≥150 and \<200 mg/dL, low density lipoprotein-cholesterol ≥130 and \<160 mg/dL,and/or high density lipoprotein-cholesterol \<40 mg/dL 3. written informed consent
Exclusion criteria
1. history of system diseases, such as cardiovascular diseases, digestive system diseases, diseases of respiratory system, blood and immune system diseases, nervous system diseases, endocrine system diseases, and diseases of the genitourinary system. 2. history of mental illness. 3. pregnant or breastfeeding. 4. use of antihypertensive, antidiabetic, or lipid-lowering drugs within the past two weeks. 5. use of fish oil capsules or other supplements containing omega-3 fatty acids within the past two weeks. 6. allergy or intolerance to fish oil, corn oil, omega-3 fatty acids, or vitamin E. 7. participation in another trial. 8. unable to promise to not use drugs and other fish oils during the study. 9. unable to provide informed written consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the improvement of suboptimal health status | three months | The improvement of suboptimal health status is evaluated by the change of the SHSQ-25 scores after intervention. |
| the improvement of traditional cardiovascular risk factors | three months | To investigate the changes of traditional cardiovascular risk factors such as blood pressure, lipids, fasting plasma glucose, and body mass index with three months supplementation of omega-3 fatty acids. Abnormal cardiovascular risk factors are defined according to the Adult Treatment Panel III criteria for metabolic syndromes and the recommendation by the Working Group on Obesity in China. The number of abnormal cardiovascular risk factors for each participant is recorded before and after intervention. If the number decreases after intervention, it means that the traditional cardiovascular risk factors have been improved. |
Countries
China
Outcome results
None listed